SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ANG Lifesciences India informs about credit rating

16 Jun 2018 Evaluate

ANG Lifesciences India has informed that has assigned Credit Rating for Rs 17.00 Crore Line of Credit (LOC). The agency has upgraded the long term rating to [ICRA] BB+ (pronounced ICRA double B plus) from [ICRA] BB- (pronounced ICRA double B minus) and the short-term rating to [ICRA] A4+ (pronounced ICRA A four plus) from [ICRA] A4 (pronounced ICRA A four).

The above information is a part of company’s filings submitted to BSE.

ANG Lifesciences Share Price

27.49 -0.02 (-0.07%)
11-May-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1282.15
Cipla 1304.70
Zydus Lifesciences 960.00
Lupin 2249.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×